Reuters logo
BRIEF-Cellectar Biosciences enters into strategic collaboration with Onconova Therapeutics
2017年9月21日 / 下午12点54分 / 1 个月前

BRIEF-Cellectar Biosciences enters into strategic collaboration with Onconova Therapeutics

Sept 21 (Reuters) - Cellectar Biosciences Inc

* Cellectar Biosciences enters into strategic collaboration with Onconova Therapeutics to develop new phospholipid drug conjugates

* Cellectar Biosciences Inc - financial terms of collaboration have not been disclosed

* Cellectar Biosciences - ‍under terms of collaboration, Onconova will provide Cellectar with several compounds, including some from family of molecules that contains briciclib​

* Cellectar Biosciences Inc - both companies will have option to advance development of any of newly conjugated PDC molecules Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below